Feasibility of high-dose paclitaxel in the conditioning regimen for autologous hematopoietic transplantation.

被引:0
|
作者
Perez-Calvo, J
Fernández-Hidalgo, O
Aramendía, JM
Rebollo, J
Salgado, E
Rifón, JJ
Prósper, F
Rocha, E
Martín-Algarra, S
机构
[1] Univ Navarra Clin, Pamplona, Spain
[2] Clin San Miguel, Pamplona, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5453
引用
收藏
页码:431B / 431B
页数:1
相关论文
共 50 条
  • [31] A PHASE 2 STUDY OF BORTEZOMIB PLUS HIGH-DOSE MELPHALAN CONDITIONING FOR AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN MULTIPLE MYELOMA
    Nishihori, T.
    Ochoa-Bayona, J. L.
    Pidala, J.
    Shain, K.
    Baz, R.
    Simonelli, C. M.
    Sullivan, D.
    Anasetti, C.
    Alsina, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S298 - S298
  • [32] High-Dose Busulfan and Melphalan as Conditioning Regimen for Autologous Peripheral Blood Progenitor Cell Transplantation in High-Risk Neuroblastoma Patients
    Molina, Blanca
    Alonso, Laura
    Gonzalez-Vicent, Marta
    Andion, Maitane
    Hernandez, Carmen
    Lassaletta, Alvaro
    Cormenzana, Maria
    Lopez-Ibor, Blanca
    Villa, Marta
    Molina, Javier
    Diaz, Miguel A.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2011, 28 (02) : 115 - 123
  • [33] The potential of amifostine in high-dose chemotherapy and autologous hematopoietic stem cell transplantation
    Phillips, GL
    SEMINARS IN ONCOLOGY, 2002, 29 (06) : 53 - 56
  • [34] Single-Agent High-Dose Melphalan as Conditioning Regimen in Autologous Hematopoietic Stem Cell Transplantation for Hodgkin's Lymphoma: Safety, and Long-Term Efficacy
    Al Hashmi, Hani
    Kaloyannidis, Panayotis
    Kafnar, Solaf
    Al Harbi, Salman
    Shaibani, Eshrak
    Mokhtar, Nihad
    Abdulbaki, Manar
    Al Darweesh, Mohammed
    Bacal, Jenifer
    Apostolidis, John
    Al Anezi, Khalid
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S130 - S131
  • [35] Duration of sweat cyclophosphamide excretion in patients undergoing a conditioning regimen of high-dose cyclophosphamide for hematopoietic stem-cell transplantation
    Tanigawa, Hiromu
    Hirohara, Masayoshi
    Marutani, Yoshinori
    Suzuki, Yuji
    Onizuka, Makoto
    Oda, Shiori
    Orita, Mutsuko
    Sato, Masayo
    Kushida, Kazuki
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (03) : 619 - 625
  • [36] The impact of HBO on early ALC recovery following high-dose therapy and autologous transplantation.
    Aljitawi, Omar Salah
    Markiewicz, Mary
    Seng, Amara
    Lin, Tara L.
    Ganguly, Siddhartha
    Mahnken, Jonathan
    Singh, Anurag
    Shune, Leyla
    Abhyankar, Sunil H.
    Lipe, Brea
    Allin, Dennis
    McGuirk, Joseph
    Yankee, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [37] High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma
    Di Ianni, Mauro
    Ballanti, Stelvio
    Iodice, Giuseppe
    Reale, Antonia
    Falzetti, Franca
    Minelli, Olivia
    Serio, Gabriella
    Martelli, Massimo F.
    Dammacco, Franco
    Vacca, Angelo
    Ria, Roberto
    HEMATOLOGY, 2012, 17 (01) : 23 - 27
  • [38] High-dose idarubicine, busulphan and melphalan as conditioning for autologous blood stem cell transplantation in multiple myeloma. A feasibility study
    Meloni, G
    Capria, S
    Trasarti, S
    Ferrazza, G
    Micozzi, A
    Petrucci, MT
    Simone, F
    Trisolini, SM
    Mandelli, F
    BONE MARROW TRANSPLANTATION, 2000, 26 (10) : 1045 - 1049
  • [39] High-dose idarubicine, busulphan and melphalan as conditioning for autologous blood stem cell transplantation in multiple myeloma. A feasibility study
    G Meloni
    S Capria
    S Trasarti
    G Ferrazza
    A Micozzi
    MT Petrucci
    F Simone
    SM Trisolini
    F Mandelli
    Bone Marrow Transplantation, 2000, 26 : 1045 - 1049
  • [40] BORTEZOMIB AND HIGH-DOSE MELPHALAN AS CONDITIONING REGIMEN BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA: EXPERIENCE IN A UNIVERSITARY HOSPITAL
    Dunia, D. M.
    Dolores, M.
    Dolores, S.
    Nuria, G.
    Miguel, D.
    Jaime, A.
    Helga, G.
    Alejandro, V.
    Sonia, H.
    Blanca, P.
    HAEMATOLOGICA, 2016, 101 : 862 - 862